カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の五価アンチモニアル市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Pentavalent Antimonials Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19524）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19524
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の五価アンチモニアル市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

五価アンチモニアル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の五価アンチモニアルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

五価アンチモニアル市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・スチボグルコン酸Na、アンチモン酸メグルミン

用途別セグメントは次のように区分されます。
・病院 調剤薬局、総合調剤薬局、オンライン調剤薬局

世界の五価アンチモニアル市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi、GlaxoSmithKline、Bristol-Myers Squibb、Maiden Pharmaceuticals、Xinhua Pharm、Albert David、Science Direct

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、五価アンチモニアル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な五価アンチモニアルメーカーの企業概要、2019年～2022年までの五価アンチモニアルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な五価アンチモニアルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別五価アンチモニアルの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの五価アンチモニアルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での五価アンチモニアル市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および五価アンチモニアルの産業チェーンを掲載しています。
・第13、14、15章では、五価アンチモニアルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 五価アンチモニアルの概要
- 種類別分析（2017年vs2021年vs2028年）：スチボグルコン酸Na、アンチモン酸メグルミン
- 用途別分析（2017年vs2021年vs2028年）：病院 調剤薬局、総合調剤薬局、オンライン調剤薬局
- 世界の五価アンチモニアル市場規模・予測
- 世界の五価アンチモニアル生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Sanofi、GlaxoSmithKline、Bristol-Myers Squibb、Maiden Pharmaceuticals、Xinhua Pharm、Albert David、Science Direct
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：スチボグルコン酸Na、アンチモン酸メグルミン
・用途別分析2017年-2028年：病院 調剤薬局、総合調剤薬局、オンライン調剤薬局
・五価アンチモニアルの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・五価アンチモニアルのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・五価アンチモニアルのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・五価アンチモニアルの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・五価アンチモニアルの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pentavalent Antimonials market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pentavalent Antimonials market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals Pharmacies accounting for % of the Pentavalent Antimonials global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sodium Stibogluconate segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pentavalent Antimonials include Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Maiden Pharmaceuticals, and Xinhua Pharm, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pentavalent Antimonials market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sodium Stibogluconate
Meglumine Antimoniate
Market segment by Application can be divided into
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Pentavalent Antimonials market are listed below:
Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pentavalent Antimonials product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pentavalent Antimonials, with price, sales, revenue and global market share of Pentavalent Antimonials from 2019 to 2022.
Chapter 3, the Pentavalent Antimonials competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pentavalent Antimonials breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pentavalent Antimonials market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pentavalent Antimonials.
Chapter 13, 14, and 15, to describe Pentavalent Antimonials sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Pentavalent Antimonials Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pentavalent Antimonials Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Sodium Stibogluconate
1.2.3 Meglumine Antimoniate
1.3 Market Analysis by Application
1.3.1 Overview: Global Pentavalent Antimonials Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pentavalent Antimonials Market Size & Forecast
1.4.1 Global Pentavalent Antimonials Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pentavalent Antimonials Sales in Volume (2017-2028)
1.4.3 Global Pentavalent Antimonials Price (2017-2028)
1.5 Global Pentavalent Antimonials Production Capacity Analysis
1.5.1 Global Pentavalent Antimonials Total Production Capacity (2017-2028)
1.5.2 Global Pentavalent Antimonials Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pentavalent Antimonials Market Drivers
1.6.2 Pentavalent Antimonials Market Restraints
1.6.3 Pentavalent Antimonials Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Pentavalent Antimonials Product and Services
2.1.4 Sanofi Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Pentavalent Antimonials Product and Services
2.2.4 GlaxoSmithKline Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Pentavalent Antimonials Product and Services
2.3.4 Bristol-Myers Squibb Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Maiden Pharmaceuticals
2.4.1 Maiden Pharmaceuticals Details
2.4.2 Maiden Pharmaceuticals Major Business
2.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Product and Services
2.4.4 Maiden Pharmaceuticals Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Xinhua Pharm
2.5.1 Xinhua Pharm Details
2.5.2 Xinhua Pharm Major Business
2.5.3 Xinhua Pharm Pentavalent Antimonials Product and Services
2.5.4 Xinhua Pharm Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Albert David
2.6.1 Albert David Details
2.6.2 Albert David Major Business
2.6.3 Albert David Pentavalent Antimonials Product and Services
2.6.4 Albert David Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Science Direct
2.7.1 Science Direct Details
2.7.2 Science Direct Major Business
2.7.3 Science Direct Pentavalent Antimonials Product and Services
2.7.4 Science Direct Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pentavalent Antimonials Breakdown Data by Manufacturer
3.1 Global Pentavalent Antimonials Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pentavalent Antimonials Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pentavalent Antimonials
3.4 Market Concentration Rate
3.4.1 Top 3 Pentavalent Antimonials Manufacturer Market Share in 2021
3.4.2 Top 6 Pentavalent Antimonials Manufacturer Market Share in 2021
3.5 Global Pentavalent Antimonials Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pentavalent Antimonials Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pentavalent Antimonials Market Size by Region
4.1.1 Global Pentavalent Antimonials Sales in Volume by Region (2017-2028)
4.1.2 Global Pentavalent Antimonials Revenue by Region (2017-2028)
4.2 North America Pentavalent Antimonials Revenue (2017-2028)
4.3 Europe Pentavalent Antimonials Revenue (2017-2028)
4.4 Asia-Pacific Pentavalent Antimonials Revenue (2017-2028)
4.5 South America Pentavalent Antimonials Revenue (2017-2028)
4.6 Middle East and Africa Pentavalent Antimonials Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pentavalent Antimonials Sales in Volume by Type (2017-2028)
5.2 Global Pentavalent Antimonials Revenue by Type (2017-2028)
5.3 Global Pentavalent Antimonials Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pentavalent Antimonials Sales in Volume by Application (2017-2028)
6.2 Global Pentavalent Antimonials Revenue by Application (2017-2028)
6.3 Global Pentavalent Antimonials Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pentavalent Antimonials Sales by Type (2017-2028)
7.2 North America Pentavalent Antimonials Sales by Application (2017-2028)
7.3 North America Pentavalent Antimonials Market Size by Country
7.3.1 North America Pentavalent Antimonials Sales in Volume by Country (2017-2028)
7.3.2 North America Pentavalent Antimonials Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pentavalent Antimonials Sales by Type (2017-2028)
8.2 Europe Pentavalent Antimonials Sales by Application (2017-2028)
8.3 Europe Pentavalent Antimonials Market Size by Country
8.3.1 Europe Pentavalent Antimonials Sales in Volume by Country (2017-2028)
8.3.2 Europe Pentavalent Antimonials Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pentavalent Antimonials Sales by Type (2017-2028)
9.2 Asia-Pacific Pentavalent Antimonials Sales by Application (2017-2028)
9.3 Asia-Pacific Pentavalent Antimonials Market Size by Region
9.3.1 Asia-Pacific Pentavalent Antimonials Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pentavalent Antimonials Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pentavalent Antimonials Sales by Type (2017-2028)
10.2 South America Pentavalent Antimonials Sales by Application (2017-2028)
10.3 South America Pentavalent Antimonials Market Size by Country
10.3.1 South America Pentavalent Antimonials Sales in Volume by Country (2017-2028)
10.3.2 South America Pentavalent Antimonials Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pentavalent Antimonials Sales by Type (2017-2028)
11.2 Middle East & Africa Pentavalent Antimonials Sales by Application (2017-2028)
11.3 Middle East & Africa Pentavalent Antimonials Market Size by Country
11.3.1 Middle East & Africa Pentavalent Antimonials Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pentavalent Antimonials Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pentavalent Antimonials and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pentavalent Antimonials
12.3 Pentavalent Antimonials Production Process
12.4 Pentavalent Antimonials Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pentavalent Antimonials Typical Distributors
13.3 Pentavalent Antimonials Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pentavalent Antimonials Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pentavalent Antimonials Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Pentavalent Antimonials Product and Services
Table 6. Sanofi Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Pentavalent Antimonials Product and Services
Table 10. GlaxoSmithKline Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Major Business
Table 13. Bristol-Myers Squibb Pentavalent Antimonials Product and Services
Table 14. Bristol-Myers Squibb Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Maiden Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Maiden Pharmaceuticals Major Business
Table 17. Maiden Pharmaceuticals Pentavalent Antimonials Product and Services
Table 18. Maiden Pharmaceuticals Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Xinhua Pharm Basic Information, Manufacturing Base and Competitors
Table 20. Xinhua Pharm Major Business
Table 21. Xinhua Pharm Pentavalent Antimonials Product and Services
Table 22. Xinhua Pharm Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Albert David Basic Information, Manufacturing Base and Competitors
Table 24. Albert David Major Business
Table 25. Albert David Pentavalent Antimonials Product and Services
Table 26. Albert David Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Science Direct Basic Information, Manufacturing Base and Competitors
Table 28. Science Direct Major Business
Table 29. Science Direct Pentavalent Antimonials Product and Services
Table 30. Science Direct Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Pentavalent Antimonials Sales by Manufacturer (2019, 2020, 2021, and 2022) & (g)
Table 32. Global Pentavalent Antimonials Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Pentavalent Antimonials, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Pentavalent Antimonials Production Capacity by Company, (g): 2020 VS 2021
Table 35. Head Office and Pentavalent Antimonials Production Site of Key Manufacturer
Table 36. Pentavalent Antimonials New Entrant and Capacity Expansion Plans
Table 37. Pentavalent Antimonials Mergers & Acquisitions in the Past Five Years
Table 38. Global Pentavalent Antimonials Sales by Region (2017-2022) & (g)
Table 39. Global Pentavalent Antimonials Sales by Region (2023-2028) & (g)
Table 40. Global Pentavalent Antimonials Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Pentavalent Antimonials Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Pentavalent Antimonials Sales by Type (2017-2022) & (g)
Table 43. Global Pentavalent Antimonials Sales by Type (2023-2028) & (g)
Table 44. Global Pentavalent Antimonials Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Pentavalent Antimonials Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Pentavalent Antimonials Price by Type (2017-2022) & (USD/mg)
Table 47. Global Pentavalent Antimonials Price by Type (2023-2028) & (USD/mg)
Table 48. Global Pentavalent Antimonials Sales by Application (2017-2022) & (g)
Table 49. Global Pentavalent Antimonials Sales by Application (2023-2028) & (g)
Table 50. Global Pentavalent Antimonials Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Pentavalent Antimonials Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Pentavalent Antimonials Price by Application (2017-2022) & (USD/mg)
Table 53. Global Pentavalent Antimonials Price by Application (2023-2028) & (USD/mg)
Table 54. North America Pentavalent Antimonials Sales by Country (2017-2022) & (g)
Table 55. North America Pentavalent Antimonials Sales by Country (2023-2028) & (g)
Table 56. North America Pentavalent Antimonials Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Pentavalent Antimonials Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Pentavalent Antimonials Sales by Type (2017-2022) & (g)
Table 59. North America Pentavalent Antimonials Sales by Type (2023-2028) & (g)
Table 60. North America Pentavalent Antimonials Sales by Application (2017-2022) & (g)
Table 61. North America Pentavalent Antimonials Sales by Application (2023-2028) & (g)
Table 62. Europe Pentavalent Antimonials Sales by Country (2017-2022) & (g)
Table 63. Europe Pentavalent Antimonials Sales by Country (2023-2028) & (g)
Table 64. Europe Pentavalent Antimonials Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Pentavalent Antimonials Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Pentavalent Antimonials Sales by Type (2017-2022) & (g)
Table 67. Europe Pentavalent Antimonials Sales by Type (2023-2028) & (g)
Table 68. Europe Pentavalent Antimonials Sales by Application (2017-2022) & (g)
Table 69. Europe Pentavalent Antimonials Sales by Application (2023-2028) & (g)
Table 70. Asia-Pacific Pentavalent Antimonials Sales by Region (2017-2022) & (g)
Table 71. Asia-Pacific Pentavalent Antimonials Sales by Region (2023-2028) & (g)
Table 72. Asia-Pacific Pentavalent Antimonials Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Pentavalent Antimonials Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Pentavalent Antimonials Sales by Type (2017-2022) & (g)
Table 75. Asia-Pacific Pentavalent Antimonials Sales by Type (2023-2028) & (g)
Table 76. Asia-Pacific Pentavalent Antimonials Sales by Application (2017-2022) & (g)
Table 77. Asia-Pacific Pentavalent Antimonials Sales by Application (2023-2028) & (g)
Table 78. South America Pentavalent Antimonials Sales by Country (2017-2022) & (g)
Table 79. South America Pentavalent Antimonials Sales by Country (2023-2028) & (g)
Table 80. South America Pentavalent Antimonials Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Pentavalent Antimonials Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Pentavalent Antimonials Sales by Type (2017-2022) & (g)
Table 83. South America Pentavalent Antimonials Sales by Type (2023-2028) & (g)
Table 84. South America Pentavalent Antimonials Sales by Application (2017-2022) & (g)
Table 85. South America Pentavalent Antimonials Sales by Application (2023-2028) & (g)
Table 86. Middle East & Africa Pentavalent Antimonials Sales by Region (2017-2022) & (g)
Table 87. Middle East & Africa Pentavalent Antimonials Sales by Region (2023-2028) & (g)
Table 88. Middle East & Africa Pentavalent Antimonials Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Pentavalent Antimonials Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Pentavalent Antimonials Sales by Type (2017-2022) & (g)
Table 91. Middle East & Africa Pentavalent Antimonials Sales by Type (2023-2028) & (g)
Table 92. Middle East & Africa Pentavalent Antimonials Sales by Application (2017-2022) & (g)
Table 93. Middle East & Africa Pentavalent Antimonials Sales by Application (2023-2028) & (g)
Table 94. Pentavalent Antimonials Raw Material
Table 95. Key Manufacturers of Pentavalent Antimonials Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Pentavalent Antimonials Typical Distributors
Table 99. Pentavalent Antimonials Typical Customers
List of Figures
Figure 1. Pentavalent Antimonials Picture
Figure 2. Global Pentavalent Antimonials Revenue Market Share by Type in 2021
Figure 3. Sodium Stibogluconate
Figure 4. Meglumine Antimoniate
Figure 5. Global Pentavalent Antimonials Revenue Market Share by Application in 2021
Figure 6. Hospitals Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Pentavalent Antimonials Revenue, (USD Million) & (g): 2017 & 2021 & 2028
Figure 10. Global Pentavalent Antimonials Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Pentavalent Antimonials Sales (2017-2028) & (g)
Figure 12. Global Pentavalent Antimonials Price (2017-2028) & (USD/mg)
Figure 13. Global Pentavalent Antimonials Production Capacity (2017-2028) & (g)
Figure 14. Global Pentavalent Antimonials Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Pentavalent Antimonials Market Drivers
Figure 16. Pentavalent Antimonials Market Restraints
Figure 17. Pentavalent Antimonials Market Trends
Figure 18. Global Pentavalent Antimonials Sales Market Share by Manufacturer in 2021
Figure 19. Global Pentavalent Antimonials Revenue Market Share by Manufacturer in 2021
Figure 20. Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Pentavalent Antimonials Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Pentavalent Antimonials Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Pentavalent Antimonials Sales Market Share by Region (2017-2028)
Figure 24. Global Pentavalent Antimonials Revenue Market Share by Region (2017-2028)
Figure 25. North America Pentavalent Antimonials Revenue (2017-2028) & (USD Million)
Figure 26. Europe Pentavalent Antimonials Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Pentavalent Antimonials Revenue (2017-2028) & (USD Million)
Figure 28. South America Pentavalent Antimonials Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Pentavalent Antimonials Revenue (2017-2028) & (USD Million)
Figure 30. Global Pentavalent Antimonials Sales Market Share by Type (2017-2028)
Figure 31. Global Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
Figure 32. Global Pentavalent Antimonials Price by Type (2017-2028) & (USD/mg)
Figure 33. Global Pentavalent Antimonials Sales Market Share by Application (2017-2028)
Figure 34. Global Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
Figure 35. Global Pentavalent Antimonials Price by Application (2017-2028) & (USD/mg)
Figure 36. North America Pentavalent Antimonials Sales Market Share by Type (2017-2028)
Figure 37. North America Pentavalent Antimonials Sales Market Share by Application (2017-2028)
Figure 38. North America Pentavalent Antimonials Sales Market Share by Country (2017-2028)
Figure 39. North America Pentavalent Antimonials Revenue Market Share by Country (2017-2028)
Figure 40. United States Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Pentavalent Antimonials Sales Market Share by Type (2017-2028)
Figure 44. Europe Pentavalent Antimonials Sales Market Share by Application (2017-2028)
Figure 45. Europe Pentavalent Antimonials Sales Market Share by Country (2017-2028)
Figure 46. Europe Pentavalent Antimonials Revenue Market Share by Country (2017-2028)
Figure 47. Germany Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Pentavalent Antimonials Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Pentavalent Antimonials Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Pentavalent Antimonials Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Pentavalent Antimonials Revenue Market Share by Region (2017-2028)
Figure 56. China Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Pentavalent Antimonials Sales Market Share by Type (2017-2028)
Figure 63. South America Pentavalent Antimonials Sales Market Share by Application (2017-2028)
Figure 64. South America Pentavalent Antimonials Sales Market Share by Country (2017-2028)
Figure 65. South America Pentavalent Antimonials Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Pentavalent Antimonials Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Pentavalent Antimonials Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Pentavalent Antimonials Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Pentavalent Antimonials Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Pentavalent Antimonials Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Pentavalent Antimonials in 2021
Figure 77. Manufacturing Process Analysis of Pentavalent Antimonials
Figure 78. Pentavalent Antimonials Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のアンフェタミン薬市場2022年：市場規模予測（～2028年）
  • 世界の金属製冠動脈ステント市場2022年：市場規模予測（～2028年）
  • 世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）
  • 世界のデジタル歯科用 X 線センサー市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19524 )"世界の五価アンチモニアル市場2022年：市場規模予測（～2028年）" (英文：Global Pentavalent Antimonials Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。